Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-03-01Clinical Trial Update: Coping in African American Prostate Cancer Survivors [NA]
Duke University sponsored a study focusing on coping strategies for African American prostate cancer survivors. The trial status is complete…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer [Phase 3]
A Phase 3 trial evaluating low, intermediate, or high doses of suramin for hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Cilengitide in Treating Patients With Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating cilengitide in metastatic prostate cancer has completed.
-
FDA approval · 2013-02-27FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval pertains t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease [Phase 1]
Phase 1 trial evaluating MR-guided focused ultrasound as focal therapy for locally non-advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer
A completed clinical trial evaluating the predictive value of the PSA isoform p2psa and its derivatives for diagnosing prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer [NA]
This Clinical Trial Update notes the completion of a study aimed at helping African American prostate cancer survivors and their partners co…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. [Phase 2]
Phase 2 trial evaluating Vandetanib with bicalutamide versus bicalutamide alone in chemotherapy-naive hormone-refractory prostate cancer, fo…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer [Phase 1]
Phase 1 trial suggests that injecting cross-linked hyaluronan gel reduces rectal toxicity from radiation therapy in men with prostate cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Assessment of New Radiation Oncology Technologies and Treatments
This clinical trial update reports completion of a study evaluating new radiation oncology technologies and treatments. The study assessed m…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy [Phase 4]
A Phase 4 clinical trial update comparing ThinSeed and OncoSeed for permanent prostate brachytherapy in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the efficacy and safety of a one-month degarelix dosing regimen in Korean patients with prostate …
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate [Phase 3]
A Phase 3 trial evaluates a new design of the iodine-125 seed to maintain its intended position when implanted in the prostate. The study re…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: APC8015 and Bevacizumab in Treating Patients With Prostate Cancer [Phase 2]
This clinical trial update reports a Phase 2 study evaluating APC8015 in combination with bevacizumab for prostate cancer. The study has com…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating flavopiridol in patients with recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 1]
Phase 1 clinical trial of a vaccine therapy for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer [Phase 3]
A Phase 3 trial evaluating postoperative radiation therapy after prostatectomy for stage III prostate cancer; the study status is completed.
-
FDA approval · 2013-02-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) by URONOVA Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Duke Urology Database and Specimen Bank
This update notes the completion of the Duke Urology Database and Specimen Bank clinical trial (NCT00978991) sponsored by Duke University, i…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors [Phase 2]
This update notes that a Phase 2 online survivorship workshop study sponsored by Stanford University has completed for cancer survivors, inc…
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate [Phase 3]
Phase 3 trial S9917 tested whether selenium could prevent cancer in men with prostate neoplasia; the study completed and posted results in 2…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial of S0354, an anti-IL-6 chimeric monoclonal antibody, in metastatic prostate cancer that did not respond to hormone therapy; th…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Trial of Iressa in Prostate Cancer Patients [Phase 2]
A Phase 2 clinical trial of Iressa (gefitinib) in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 trial of BMS-275291 in hormone-resistant prostate cancer has completed. The study enrolled men with advanced disease, including thos…